Pharmalot -- The two television commercials for the Yaz birth control pill overstated effectiveness, minimized risks and wrongly suggested the pill is approved for relieving premenstrual syndrome, according to an October 3 warning letter sent to the drugmaker and posted on the FDA web site.
